Amulet vs Watchman Comparison Still Muddy Any Which Way LAA Leaks Are Defined
SAN FRANCISCO — Two mainstream devices for percutaneous left atrial appendage (LAA) closure continued to lead to similar clinical outcomes in the SWISS-APERO trial. Among patients randomized to the Amplatzer Amulet and the Watchman 2.5/FLX, the incidence of patent LAAs at 13 months reached 53.6% and 48.8%, respectively, on coronary CT angiography (risk ratio [RR] […]